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ABSTRACT Steric effects can influence the binding of a cell surface receptor to a multivalent ligand. To account for steric
effects arising from the size of a receptor and from the spacing of binding sites on a ligand, we extend a standard
mathematical model for ligand-receptor interactions by introducing a steric hindrance factor. This factor gives the fraction of
unbound ligand sites that are accessible to receptors, and thus available for binding, as a function of ligand site occupancy.
We derive expressions for the steric hindrance factor for various cases in which the receptor covers a compact region on the
ligand surface and the ligand expresses sites that are distributed regularly or randomly in one or two dimensions. These
expressions are relevant for ligands such as linear polymers, proteins, and viruses. We also present numerical algorithms that
can be used to calculate steric hindrance factors for other cases. These theoretical results allow us to quantify the effects of
steric hindrance on ligand-receptor kinetics and equilibria.
INTRODUCTION
For many cell surface receptors, interaction with a multiva-
lent ligand is essential for signal transduction (Metzger,
1992). Multivalent ligand-receptor binding leads to aggre-
gation of receptors, phosphorylation of intracellular recep-
tor domains, and activation of cytoplasmic regulatory mol-
ecules. These receptors include multichain immune
recognition receptors (Keegan and Paul, 1992), such as the
B cell receptor, and receptor tyrosine kinases (Pazin and
Williams, 1992; Fry et al., 1993), such as the epidermal
growth factor receptor. Multivalent ligand-receptor binding
is important not only in signal transduction, but also in a
variety of other phenomena, such as antibody-mediated
activation of the complement cascade (Burton and Woof,
1992) and viral attachment and entry into cells (Haywood,
1994).
Because of the importance of multivalent ligand-receptor
binding, significant effort, involving both experimental and
theoretical work, has been directed at understanding the
interactions of multivalent ligands with cell surface recep-
tors. Theoretical work on bivalent ligands (Dembo and
Goldstein, 1978; Perelson and DeLisi, 1980) has been par-
ticularly influential. The theory for these ligands has been
refined over a number of years (Posner et al., 1995b) and
applied to a number of problems, particularly the analysis of
FcRI aggregation on the surface of rat basophilic leukemia
cells (Goldstein, 1988; Goldstein and Wofsy, 1994). Theo-
retical work on multivalent ligands (Gandolfi et al., 1978;
DeLisi, 1980; Perelson, 1981) has also been applied to a
number of problems in immunology and virology (Hlavacek
et al., 1999; Sulzer and Perelson, 1997; Dee and Shuler,
1997; Goldstein and Wofsy, 1996; Wickham et al., 1990,
1995; Segal et al., 1983; Vogelstein et al., 1982; Dower and
Segal, 1981; Dower et al., 1981). However, models for
multivalent ligands have yet to be fully developed.
When the valence of a ligand is greater than two, models
for ligand-receptor binding are complicated by a number of
factors (Perelson, 1984; Macken and Perelson, 1985;
Lauffenburger and Linderman, 1993). One complication
arises when a bound receptor, because of its physical size,
excludes receptor binding at neighboring ligand sites. Steric
exclusion of ligand sites by bound receptors is illustrated in
Fig. 1. Shown schematically is the surface of a multivalent
ligand that is bound to two receptors. Each receptor binds a
single site but physically covers an area that encompasses
more than one site on the ligand. Sites on the ligand are
bound or unbound, and unbound sites are covered, ex-
cluded, or available. A covered site is unavailable for re-
ceptor binding, because it is covered by a bound receptor.
Likewise, an excluded site, although it is not covered, is
unavailable for receptor binding because it lies near a bound
receptor, and binding at this site would require an overlap of
receptors. A covered or excluded site is distinguished from
an available site, at which receptor binding is possible.
Steric exclusion of ligand sites by bound receptors reduces
the average reactivity of unbound ligand sites: available
sites have the potential to bind receptors, but covered and
excluded sites do not.
Steric exclusion of ligand sites is likely to play a role in
many ligand-receptor interactions, as suggested by the in-
teractions of antibodies with various types of antigens.
Steric effects due to ligand site exclusion can be important
in antibody binding to viruses. For example, the protein coat
of tobacco mosaic virus (TMV), a nonenveloped virus,
consists of 2130 repeating subunits, but subunit-specific,
excess monoclonal antibody binds TMV with a stoichiom-
etry of 800:1, which suggests that a bound antibody Fab arm
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covers approximately three viral subunits (Pellequer and
Van Regenmortel, 1993). Steric effects due to ligand site
exclusion also can be significant in antibody binding to
bacterial polysaccharides. Galactan from Prototheca zopfii
is composed of 1240 galactosyl residues. Galactan-spe-
cific antibodies, which can bind at sites along the entire
polysaccharide chain, each cover at least 10 and as many as
30 sequential galactosyl residues when bound (Glaudemans
et al., 1986). Steric effects can also be important in antibody
binding to protein antigens, because the whole surface of a
protein is potentially antigenic (Davies and Cohen, 1996)
and domains important for protein-protein binding are
smaller than protein-protein interfaces (Wells, 1996). Inter-
actions of antibodies with densely haptenated carrier mole-
cules are also likely to involve steric effects (Macken and
Perelson, 1986; Hlavacek et al., 1999).
Here we develop a theoretical framework for modeling
multivalent ligand-receptor binding when steric effects due
to ligand site exclusion are important. In this framework,
steric effects on cross-linking reactions are characterized by
a steric hindrance factor. This factor indicates how the
accessibility, and thus the average reactivity, of unbound
ligand sites depends on ligand site occupancy. Steric hin-
drance factors are closely related to insertion probabilities
(Widom, 1963). An insertion probability is the probability
of inserting a particle onto a surface without overlap when
the surface is partially covered with other particles. By
adapting the method of Andrews (1975, 1976) for calculat-
ing insertion probabilities, we are able to derive expressions
for steric hindrance factors for various types of ligands and
receptors.
In our derivation of steric hindrance factors, we focus on
receptors that cover a compact region on the ligand surface
when bound, but we consider different types of ligands with
binding sites distributed regularly or randomly in one or two
dimensions. The one-dimensional results, which comple-
ment earlier work (Macken and Perelson, 1986), are rele-
vant for linear polymers to which haptens have been con-
jugated at random positions or a polysaccharide with
regularly spaced epitopes. The two-dimensional results are
relevant for ligands such as multisubunit proteins, hapte-
nated proteins, surface proteins on enveloped viruses, or
whole nonenveloped viruses. Our expressions for steric
hindrance factors are approximate, except for special one-
dimensional cases. To determine the accuracy and useful-
ness of these approximations, we compare approximate
results with those calculated via Monte Carlo or combina-
toric methods.
THEORY
Here we develop a model for ligand-receptor binding that
includes steric effects. We focus on a multivalent ligand that
interacts with a monovalent receptor. The ligand is assumed
to be symmetrical and much smaller than a cell, and binding
sites on the ligand are assumed to be chemically identical.
We allow for various arrangements of ligand sites. The
receptor is mobile and disperse on the cell surface. We
assume that receptor trafficking is inhibited such that the
total amounts of ligand and receptor are each constant
(Lauffenburger and Linderman, 1993). Steric effects arise
when bound receptors hinder access to ligand sites, as
illustrated in Fig. 1. In the absence of steric effects, the model
reduces to the well-studied equivalent site model for multiva-
lent ligand-receptor binding (Perelson, 1984; Macken and Per-
elson, 1985; Lauffenburger and Linderman, 1993).
Valence
We define the following ligand valences (Fig. 2): v, f, n, and
(i) for i  1, . . . , f. The valence v is the number of sites
FIGURE 1 The surface of a ligand on which two receptors are bound.
Ligand sites are bound, covered, excluded, or available, as indicated. A
darkly shaded region represents the circular area a that is covered by each
receptor. A lightly shaded region represents the “exclusion area” of each
receptor, an annular region of area 3a in which sites cannot be bound
without overlap of receptors. Note that sites combine with receptors at the
center of the area covered by a bound receptor.
FIGURE 2 A ligand-receptor complex. Bound, covered, excluded, and
available sites on the ligand are represented as in Fig. 1. Initially, the ligand
can attach to the cell surface at any of 18 sites (v  18). However, because
of the geometry of this ligand, once the ligand is anchored to the cell
surface, only nine of the 18 sites, those that are directed at the cell surface,
are in position to interact with receptors. Thus n  9. After a site is bound
by a receptor, the number of sites available for further binding depends on
the particular site at which the receptor is bound. The average number of
sites that are available for receptor binding when the ligand is bound at a
single site is (6  5  4  4  4  4  4  5  6)/9. Thus (1)  14/3.
Likewise, we can determine that (2) 62/45 and (3) 0. At most, three
sites on the ligand can be bound simultaneously by receptors ( f  3). A
bound receptor can contact up to three ligand sites (  3).
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on a ligand in solution at which a receptor can bind, and the
effective valence f is the maximum number of sites on a
ligand that can be bound simultaneously by receptors (Per-
elson, 1981, 1984). The exposure valence n is a new con-
cept: we define it as the number of sites on a ligand that are
exposed to receptors when the ligand is anchored to the cell
surface. As illustrated in Fig. 2, a bound ligand may expose
only a fraction of its sites to receptors. We also define for
the first time the valence of the ith bound state (i) for i 
1, . . . , f. Each  (i) is the number of ways in which a ligand
bound at i sites can be converted to a ligand bound at i  1
sites, i.e.,  (i) is the number of sites that are available for
receptor binding on a ligand that is bound at i sites averaged
over all possible microscopic states of the ligand. The
quantity  (i) will also be called the number of available
sites. Note that  ( f )  0, because no further binding can
occur once f sites are bound, and that  (i)  n  i. If each
exposed site on a ligand is always available for receptor
binding, then f  n and  (i)  n  i. However, if ligand
sites can be covered or excluded by bound receptors, as
illustrated in Figs. 1 and 2, then f  n and  (i)  n  i.
Reaction scheme
Our model for ligand-receptor binding is based on the
reaction scheme shown in Fig. 3. In this scheme, ligand-
receptor binding proceeds through a series of reversible
reactions. The initial reaction involves the binding of a
solution-phase ligand to a receptor, and each subsequent
reaction involves the addition of a receptor to a ligand-
receptor complex on the cell surface. As indicated in Fig. 3,
the model is developed in terms of ligand states. Variables
in the model include the concentration of ligand in solution,
which is denoted as L0; the surface density of ligand that is
bound at i sites, which is denoted as Li; and the surface
density of free receptors, which is denoted as R.
Equilibria
For the initial reaction in Fig. 3,
L1 vKRL0 (1)
where K is an equilibrium constant that represents the
affinity of a receptor for a site on solution-phase ligand. For
each subsequent reaction in Fig. 3,
i 1Li1 iKxRLi i 1, . . . , f 1 (2)
where Kx is a two-dimensional cross-linking equilibrium
constant that represents the affinity of a receptor site for an
available site on surface-adsorbed ligand. The coefficient
(i  1) in this equation represents the number of ways that
a receptor can dissociate from a ligand bound at i  1 sites.
Kinetics
The kinetics of ligand-receptor binding are difficult to
model when steric effects influence binding, because to
determine exact time courses of binding, we must write a
kinetic balance equation for each microscopic ligand state
(Epstein, 1979a,b; Munro et al., 1998). Nevertheless, exact
tractable models can be developed for limiting cases (Ep-
stein, 1979a,b; Schaaf and Talbot, 1989; Evans, 1993).
Below, we present a model that is exact for the limiting case
in which microscopic equilibrium is established instanta-
neously and approximate otherwise. Instantaneous estab-
lishment of microscopic equilibrium (IEME) occurs when
ligands bound at i sites effectively redistribute themselves
immediately among all possible microscopic states when-
ever a ligand enters or leaves the ith bound state. Micro-
scopic equilibrium, which is a necessary condition for bind-
ing equilibrium, allows us to characterize the number of
available sites on a ligand in a particular bound state at a
particular time by the expected number of available sites at
equilibrium. The IEME approximation improves as the rate
of receptor dissociation increases, and this approximation is
least accurate when receptor binding is irreversible. The
usefulness of the IEME approximation can be determined
by comparing approximate and exact results, which can be
determined with numerical methods (Epstein, 1979b; Reiter
and Epstein, 1990; Sild et al., 1996).
Given IEME, a kinetic description of ligand-receptor
binding is provided by
dL0/dtCv kfRL0 krL1
dL1/dt v kfRL0 krL1 1kxRL1 2kxL2
dLi/dt i 1kxRLi1 ikxLi
 ikxRLi i 1kxLi1
for i 2, . . . , f 1 (3)
dLf/dt  f 1kxRLf1 f kxLf
where kf is the forward rate constant for initial binding of a
ligand to a receptor, kr is the corresponding reverse rate
constant, kx is the forward cross-linking rate constant for the
addition of a receptor to a ligand-receptor complex on the
cell surface, and kx is the corresponding reverse rate con-
stant. The constant C is a factor that converts surface
FIGURE 3 Reaction scheme. At each step in this scheme, the following
reaction takes place: Free receptor  Free ligand site º Bound receptor.
The first step involves the attachment of solution-phase ligand to a cell-
surface receptor. Each subsequent step involves the addition of a receptor
to a ligand-receptor complex on the cell surface. R indicates a receptor, L0
indicates a ligand in solution, and L1 and L2 indicate ligands that are bound
to one and two receptors, respectively.
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densities to concentrations, e.g., C is the cell concentration
if surface densities are expressed on a per cell basis. Equa-
tion 3 is appropriate for reaction-limited binding. If diffu-
sion of ligand to the cell surface were limiting, then the rate
constants in Eq. 3 would have to be modified (Berg and
Purcell, 1977; DeLisi and Wiegel, 1981; Shoup and Szabo,
1982; Goldstein, 1989; Goldstein et al., 1989; Lauffen-
burger and Linderman, 1993).
Conservation
Conservation of ligand can be expressed as
LT L0 C 
i1
f
Li (4)
where LT is the total concentration of ligand. Similarly,
conservation of receptor can be expressed as
RT R 
i1
f
iLi (5)
where RT is the total surface density of receptors.
Steric effects
To account for steric effects, we must determine how the
number of available sites (i) varies with ligand site occu-
pancy i. The fraction of exposed ligand sites that are avail-
able for receptor binding is given by (i)/n, which can be
interpreted as the probability that an exposed site is avail-
able for receptor binding. This probability, which we denote
as Pi(), is called the insertion probability, because if we
were to attempt to add an additional receptor to a ligand-
receptor complex at a randomly chosen site on the ligand,
Pi() is the probability that this insertion attempt is suc-
cessful. Several approaches are available for calculating
insertion probabilities. Here we follow an approach of An-
drews (1975, 1976) to develop expressions for Pi() for
ligands with sites distributed randomly or ordered regularly
in one or two dimensions.
Ligands with sites distributed randomly on a
two-dimensional surface
Let us focus on the case illustrated in Fig. 1. A ligand is
bound at i sites, and the ligand exposes n sites, which are
distributed randomly over an area A, to receptors on the cell
surface. A bound receptor covers a circular area a on the
ligand surface. Later, we will consider cases in which a is
noncircular. We assume that a  A, such that edge effects
are negligible.
As illustrated in Fig. 1, an exposed ligand site is in one of
four states: it is bound (), covered (), excluded (), or
available (). The probability that a site is available can be
expressed as the following product:
Pi Pi Pi   Pi     (6)
where Pi( ) is the probability that a site is not bound;
Pi(   ) is the conditional probability that a site is not
covered, given that it is not bound; and Pi(    ) is the
conditional probability that a site is not excluded, given that
it is neither bound nor covered. We can determine Pi( ) and
Pi(   ) exactly, and we can determine Pi(    ) approxi-
mately.
The probability that a site is not bound, Pi( ), is related
to the probability that a site is bound Pi(): Pi( )  1 
Pi(). Because Pi() is equivalent to the fraction of ex-
posed sites that are bound, i/n,
Pi  1 i/n (7)
The probability that a site is not covered given that it is not
bound, Pi(   ), is related to the probability that it is cov-
ered given that it is not bound Pi(  ): Pi(   )  1 
Pi(  ). Because Pi(  ) is equivalent to the fraction of
the exposed ligand surface that is covered by bound recep-
tors ia/A,
Pi    1 ia/A (8)
The product Pi( )Pi(   )  (1  i/n)(1  ia/A) is the
probability that a site is neither bound nor covered.
If a site is neither bound nor covered, then it lies some-
where in an area of size A  ia. Sites in this area are either
excluded or available. A site is excluded if it lies within the
“exclusion area” of a bound receptor. As illustrated in Fig.
1, the exclusion area of a receptor that covers a circular area
a is an annular region of area 3a that surrounds a. Thus the
probability that a site is excluded by a given bound receptor
is 3a/(A  ia), and the probability that the site is not
excluded by this particular receptor is 1  3a/(A  ia).
Following Andrews (1975, 1976), we estimate Pi(    ),
the probability that a site is not excluded by any of the i
receptors, as the ith power of the probability that a site is not
excluded by a given receptor. Thus,
Pi     1 3aA ia
i
(9)
This expression implies mutually independent events. In
other words, the probability that a site is excluded by the
first receptor in Fig. 1 is independent of whether the site is
excluded by the second receptor. In general, this is an
approximation, because the exclusion areas of two receptors
can overlap, as depicted in Fig. 1.
By combining Eqs. 6–9, we obtain an expression for the
insertion probability for the case illustrated in Fig. 1:
Pi 1 in1 iaA1 3aA ia
i
(10)
This expression also yields an expression for (i), which can
be substituted into the model equations (Eqs. 1–5), because
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(i)  nPi(). The general method that we have used to
derive Eq. 10 is applied below to derive expressions for
several other cases.
Equation 10 can be generalized for receptors that cover
any convex area a by using the results of Boublı´k (1975).
These results indicate that the exclusion area of a receptor
that covers an area a is (2	  1)a if a is convex and if
receptors bind in random orientations. The shape factor 	 

1 is defined as s2/(4a), where s is the perimeter of a. This
factor has a value of 1 for many shapes. If a is disk
shaped, then 	 1, and the exclusion area is 3a, as expected
(Fig. 1). If a is equilateral triangular, 	  3	3/ 
 1.6. If
a is square, 	 4/
 1.3. If a is hexagonal, 	 2	3/

1.1. In general, if a is a regular polygon with k sides, 	 
(k/)tan(/k). If a is rectangular with aspect ratio  2 (the
length of the longer side is twice that of the shorter side),
	  9/(2) 
 1.4. In general, if a is rectangular with aspect
ratio  
 1, 	  (  1)2/(). These results indicate that
insertion probabilities are somewhat insensitive to the shape
of a as long as a is compact. The generalized form of Eq. 10
is given in Table 1 (Case 1).
Ligands with sites ordered regularly on a
two-dimensional surface
If ligand sites are ordered regularly on a lattice instead of
distributed randomly, then we can adapt the results of
Stankowski (1983) to calculate the insertion probability
Pi(). These results were derived originally for adsorption
reactions, also by using the approach of Andrews (1975,
1976). Earlier, we characterized the ligand-receptor inter-
face with an area a, but here we characterize this interface
with the contact number , which represents the number of
adjacent sites that are bound or covered by a bound receptor.
The pattern of ligand sites contacted by a receptor must be
symmetrical; a hexagonal contact pattern is illustrated in
Fig. 4. Exact expressions for Pi( ) and Pi(   ) and an
approximate expression for Pi(    ) are given in Table 1
(Case 2). This latter expression involves an excluded-area
parameter , which depends on the contact pattern of the
receptor and the lattice of ligand sites. A recipe for calcu-
lating the excluded-area parameter is given by Stankowski
(1983). For a ligand with sites arranged on a square lattice
and a square contact pattern,   3  (4	  1)/, where
  [1, 4, 9, . . .]. For a ligand with sites arranged on a
hexagonal lattice and a hexagonal contact pattern (Fig. 4),
  3  	12  3/, where   [1, 7, 19, . . .].
Ligands with sites distributed randomly along a
one-dimensional array
For a ligand with sites distributed randomly along a one-
dimensional array, expressions for Pi( ), Pi(   ), and
Pi(    ) are given in Table 1 (Cases 3 and 4). The deri-
vation of these expressions is analogous to the derivation of
Eqs. 7–9. In the expressions of Table 1, the parameter L,
which is analogous to A, represents the total length of the
array of sites exposed to receptors, and the parameter l,
which is analogous to a, represents the length of the array
that is covered by a bound receptor. The expressions for
TABLE 1 Theoretical expressions for calculating insertion probabilities and steric hindrance factors
Case Arrangement of sites on the ligand Pi(   ) Pi(    )
1* Randomly distributed on 2-D surface 1  ia/A 1  2	  1 aA ia
i
2# Ordered on regular 2-D lattice 1  i  1n i 1   n i
i
3§ Randomly distributed on 1-D ring 1  il/L 1  lL il
i
4 Randomly distributed on 1-D chain 1  il/L above  1  lL il
5¶ Ordered on regular 1-D lattice ring 1  i  1n i  j11 1  in i  1 j
6 Ordered on regular 1-D lattice chain 1  i  1n i above  1   1n i  1
On a ligand bound at i sites, the expected number of sites available for receptor binding, (i), is given by nPi() or (n  i)H(i), where n is the number
of sites exposed to receptors, Pi()  Pi( )Pi(   )Pi(    ) is the insertion probability, and H(i)  Pi(   )Pi(    ) is the steric hindrance factor.
Expressions for Pi(   ) and Pi(    ) are given above for cases discussed in the text. In all six cases, Pi( )  1  i/n.
*Sites exposed to receptors are distributed over an area A. A receptor binds with random orientation and covers an area a, which is convex. The shape of
a determines the shape factor 	  s2/(4a), where s is the perimeter of a.
#A bound receptor contacts  adjacent symmetrically arrayed sites (Fig. 4). The excluded-area parameter  is determined according to the recipe of
Stankowski (1983).
§Sites exposed to receptors are arrayed along a length L. A bound receptor covers a length l.
¶A bound receptor contacts  sequential sites.
If receptors can bind at edge sites, n in these expressions is replaced by n    1 and (i)  (n    1  i)H(i) (cf. Eq. 11).
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Pi( ) and Pi(   ) are exact. The expression for Pi(    )
also is exact when L/l n, but it is approximate otherwise.
The expressions given for Case 3 in Table 1 are for a ligand
with sites distributed along a ring, i.e., a closed one-dimen-
sional array. The expressions given for Case 4 in Table 1 are
for a ligand with sites distributed along a chain, i.e., an open
one-dimensional array. The expressions for the two cases
are essentially the same, except that Pi(    ) is multiplied
by a factor to account for edge effects when sites are
ordered along a chain instead of a ring. This factor is 1 
l/(L  il), where l/(L  il) is the probability that a site is
excluded because it is close to an edge. We assume that a
site is excluded because of edge effects if a receptor is
unable to bind at that site entirely within the length L, as
might be the case if the receptor, in addition to binding the
ligand site, requires nonspecific interactions over a larger
contact area. If receptor binding is possible at such a site,
then the expressions for Case 4 in Table 1 can be used to
determine a lower bound on the insertion probability.
Ligands with sites ordered regularly along a
one-dimensional array
For a ligand with sites ordered along a ring and a receptor
that contacts  sequential sites, we can calculate Pi( ),
Pi(   ), and Pi(    ) exactly. The results are summarized
in Table 1 (Case 5). When   n, the expression for
Pi(    ) reduces to (1  i/(n  i(  1)))
1, which
corresponds to the result of McGhee and von Hippel (1974)
for an infinite lattice. If sites on a ligand are ordered along
a chain, as depicted in Fig. 2, rather than along a ring, then
the expressions for Pi( ), Pi(   ), and Pi(    ) are es-
sentially the same, except that Pi(    ) is multiplied by a
factor to account for edge effects (Table 1, Case 6). When
a receptor is unable to bind at “edge” sites (i.e., sites at
which a bound receptor would contact fewer than  sites),
the correction factor is 1  (  1)/(n  i(  1)), where
(  1)/(n  i(  1)) is the probability that a site is an
edge site. As before, the expressions for Pi( ), Pi(   ), and
Pi(    ) are exact. If receptors are able to bind at edge
sites, the expressions for Case 6 in Table 1 can be used to
obtain exact results. We simply replace n with n    1,
i.e., we introduce   1 virtual edge sites.
The steric hindrance factor
To connect our model equations with the equivalent site
model (Perelson, 1984; Lauffenburger and Linderman,
1993), we introduce the following formalism. We define
H(i) for i  1, . . . , f  1 as (i)/(n  i), which is the
fraction of exposed unbound ligand sites that are available
for receptor binding. Thus,
i n iHi (11)
and
Hi
i/n
1 i/n

Pi
Pi 
 Pi   Pi     (12)
We can interpret H(i)  1 as a factor that corrects for steric
hindrance. In the absence of steric effects, H(i) 1, because
(i)  n  i, as discussed earlier. When H(i)  1 for all i,
the model equations (Eqs. 1–5) reduce to the equivalent site
model. In the presence of steric effects, H(i)  1, because
(i)  n  i, as discussed earlier. The smaller the value of
H(i), the larger the effect of steric hindrance on ligand-
receptor binding.
METHODS
Algorithms
The insertion probability Pi() is equivalent to (i)/n, and
the steric hindrance factor H(i) is equivalent to (i)/(n  i).
Thus, Pi() and H(i) can be calculated from (i). To deter-
mine (i) directly, we specify the geometry of a ligand-
receptor interface and the spacing of exposed ligand sites.
Then we count the number of sites that are available on
average for the different microscopic bound states of the
ligand. Here, we present two algorithms for calculating
insertion probabilities that are based on this approach: a
combinatoric algorithm, which is efficient when n is small,
and a Monte Carlo algorithm, which is efficient when n is
large. The Monte Carlo algorithm is similar to that used by
Siepmann et al. (1992) to calculate insertion probabilities
for fluids of hard rods and disks.
Combinatoric algorithm
A configuration of n ligand sites is generated. A recursive
procedure then is used to generate every possible configu-
ration of i bound receptors (Taylor et al., 1991). If a con-
figuration of receptors is acceptable, meaning that none of
the i receptors overlap, then the number of available sites is
counted. A site is available if a receptor can be placed at that
site without overlapping other receptors. We compute the
number of available sites averaged over all acceptable con-
FIGURE 4 A hexagonal pattern of ligand-receptor contacts on a ligand
with a hexagonal lattice of sites. As shown, a bound receptor contacts
seven sites (  7 and   12/7). The area covered by a bound receptor
is indicated by the shaded region. Bound, covered, excluded, and available
sites on the ligand are represented as in Fig. 1.
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figurations of receptors. For ligands with randomly distrib-
uted sites, multiple configurations of sites are generated,
and the above process is repeated for each configuration.
The efficiency of the algorithm varies inversely with n!/
[(n i)!i!], which is the number of ways that i receptors can
be distributed among n ligand sites. A similar but more
efficient algorithm has been described (Badcoe, 1992) that
can be used with one-dimensional ligands that have regu-
larly ordered sites.
Monte Carlo algorithm
Initialization. A configuration of n ligand sites is generated.
We then attempt to distribute i receptors among these sites
such that none of the receptors overlap. The receptors are
placed at i randomly chosen but distinct sites. Each receptor,
except the first, is then checked for overlap in sequential
order. If a receptor overlaps another receptor, we attempt to
move it to an unbound site. If all attempts to move a
receptor to an unbound site result in overlap, we randomly
redistribute the i receptors among the n sites and attempt to
eliminate overlap as before. If an acceptable distribution of
receptors cannot be obtained after a fixed number of at-
tempts, we abandon the configuration of sites, i.e., we
assume that this configuration of n ligand sites does not
permit the binding of i receptors. Because this procedure
may abandon configurations of sites that do indeed permit
the binding of i receptors, extreme caution must be exer-
cised when calculating small insertion probabilities, for
which the algorithm is inefficient in any case.
Execution of a Monte Carlo cycle. After an initial con-
figuration of i nonoverlapping receptors is generated, we
then generate a new configuration of receptors by executing
a Monte Carlo cycle. In a Monte Carlo cycle, we sequen-
tially attempt to move each of the i receptors once from its
present ligand site sj to a neighboring ligand site sk. A move
is rejected if it results in an overlap of receptors. If the move
results in no overlap, it is accepted with probability min(Nj/
Nk, 1), where Nj is the number of sites that neighbor site sj
and Nk is the number of sites that neighbor site sk. This
acceptance criterion is necessary to ensure that a move from
site sj to sk is as likely as a move from site sk to sj. The
neighborhood of a site is defined as the collection of sites
within a fixed distance of the site. This distance is chosen so
that a site’s expected number of neighbors is well above 1.
After each Monte Carlo cycle, the number of available sites
on the ligand is determined. We perform a fixed number of
Monte Carlo cycles and compute the average number of
available sites. For ligands with randomly distributed sites,
multiple configurations of ligand sites are generated, and the
above process, including the initialization procedure, is
repeated for each configuration.
Calculating insertion probabilities
For ligands with n 20, we use the combinatoric algorithm,
whereas for ligands with n  20, we use the Monte Carlo
algorithm. We use periodic boundary conditions in all cal-
culations. For ligands with randomly distributed sites, each
reported insertion probability is the mean of 100 computa-
tional runs. To obtain reproducible results, we adjust algo-
rithmic parameters so that the standard deviation divided by
the mean is less than 0.1.
Calculating equilibrium states
Calculation of equilibrium states is aided by combining Eqs.
1, 2, 4, and 5, which yields
1 R/RT
vKLT i1f ii
n vKCRT i1f i , (13)
where
i KxRT
i1R/RTi 
j1
i n j 1j H j 1 (14)
We adopt the convention that H(0)  1. If H(j  1)  1 for
j  1, . . . , i, then the product in Eq. 14 reduces to the
statistical factor n!/[(n  i)!i!].
When values for the parameters (v, n, C, LT, RT, K, and
Kx) are specified and a value for the steric hindrance factor
H(i) is specified for i  1, . . . , f  1, Eq. 13 is a nonlinear
equation involving a single unknown: the fraction of free
receptors R/RT. To determine the fraction of free receptors
at equilibrium, we solve this equation by using the method
of bisection (Press et al., 1992). Once R/RT is known, other
states at equilibrium can be determined by using the rela-
tions L0/LT  n/[n  vKCRT i1
f (i)] and Li/RT 
(L0/LT)(vKLT/n)(i), which are derived from Eqs. 1, 2,
and 4.
Calculating time courses
To calculate time courses of ligand-receptor binding, we
solve an initial value problem that involves f differential
equations and two auxiliary algebraic equations. These
equations are derived from Eqs. 3–5 by using K  kf /kr and
Kx  kx/kx and by introducing dimensionless variables:
 kxt, r R/RT, l L0/LT, and xi Li/RT for i 1, . . . ,
f. From Eq. 3, we obtain
dxi/d  ui1 ui , for i 1, . . . , f (15)
where
u0  rxi(k r /kx)[(vKLT)rl  x1],
ui  (n  i)H(i)(KxRT)  (i  1)xi1
for i  1, . . . , f  1, and uf  0. From Eqs. 4 and 5, we
obtain
l 1 CRT/LT
i1
f
xi (16)
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and
r 1 
i1
f
ixi (17)
If we consider a system in which all ligand molecules are
initially in solution, then r  1, l  1, and xi  0 for i 
1, . . . , f at   0. These initial conditions and Eqs. 15–17
define an initial value problem, which we solve numerically
by using the FORTRAN subroutine LSODE (http://www.
netlib.org/odepack; Hindmarsh, 1983).
Quantifying receptor aggregation
A ligand bound at i sites is bound to i receptors. Thus the
fraction of receptors in ligand-induced aggregates of i or
more receptors is given by
i 
ji
f
jLj/RT (18)
The fraction of receptors in aggregates of all sizes, which
has been proposed as a measure of the extent of receptor
cross-linking (Gandolfi et al., 1978; Perelson, 1981), is
given by (2). Receptor aggregates of size 10 or more,
termed immunons, have been suggested to be the minimum
signaling unit for B cells (Dintzis et al., 1976, 1983). The
fraction of receptors in immunons is given by (10).
RESULTS
We have developed a model for ligand-receptor binding
(Eqs. 1–5) in which (i) represents the expected number of
ligand sites that are available for receptor binding when a
ligand is bound at i sites. We have related (i), which is
sensitive to steric effects (Figs. 1 and 2), to a steric hin-
drance factor H(i)  1 (Eq. 11). When H(i)  1 for all i,
Eqs. 1–5 reduce to an equivalent site model (Perelson, 1984;
Lauffenburger and Linderman, 1993). The steric hindrance
factor H(i) is related to the insertion probability Pi() (Eq.
12), the probability that a site on a ligand is available for
receptor binding when the ligand is bound at i sites. By
following the approach of Andrews (1975, 1976), we have
derived exact or approximate expressions for Pi() for
different types of ligands and receptors (Table 1). Below,
we examine the accuracy of these expressions. We also
examine steric effects on ligand-receptor binding at equi-
librium and steric effects on time courses of ligand-receptor
binding.
Accuracy of theoretical expressions
Theoretical expressions for the insertion probability Pi()
and the steric hindrance factor H(i) are given for six cases in
Table 1. Expressions for the first four cases are approxi-
mate, whereas expressions for the last two cases are exact.
The accuracy of these expressions is illustrated in Figs. 5
and 6, in which insertion probabilities calculated using the
expressions in Table 1 are compared with those calculated
using the Monte Carlo algorithm.
In Fig. 5, results are shown for ligands with regularly
ordered sites. In each panel, we consider three ligands,
which interact with the same receptor. The ligands have
different numbers of sites but are otherwise identical. The
solid and broken lines in Fig. 5 A are based on the expres-
sion for Pi() for Case 5 in Table 1, which is exact. Thus
comparison of these results with the corresponding numer-
ical results, which are represented by points, provides a test
of our Monte Carlo algorithm for calculating insertion prob-
abilities. As expected, the theoretical and numerical results
are indistinguishable. The solid and broken lines in Fig. 5 B
are based on the expression for Pi() for Case 2 in Table 1,
which is approximate. Despite the approximate nature of
these results, they agree closely with the corresponding
numerical results. The potential for this level of accuracy is
consistent with earlier observations (Stankowski, 1984).
FIGURE 5 Insertion probabilities for ligands with regularly ordered
sites. The fraction of sites available for receptor binding, Pi()  (i)/n, is
plotted as a function of the fraction of sites bound, i/n. (A) The lattice of
ligand sites is linear (Case 5 in Table 1). The solid line corresponds to a
ligand with n  400 and   5. The broken line corresponds to a ligand
with n  200 and   3. (B) The lattice of ligand sites is square (Case 2
in Table 1);   3  (4	  1)/. The solid line corresponds to a ligand
with n 676 and  25. The broken line corresponds to a ligand with n
169 and   9. In each panel, the dotted line corresponds to a ligand with
H(i)  1. Numerical results are represented by points.
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In Fig. 6, results are shown for ligands with randomly
distributed sites. In each panel, we consider four ligands,
three with different numbers of sites and one with ordered
sites, all of which can be bound simultaneously by recep-
tors. The theoretical results, which are based on expressions
in Table 1, can be compared with the corresponding numer-
ical results. As can be seen, the theoretical expressions are
capable of predicting how insertion probabilities, and there-
fore steric effects, vary with the number of binding sites on
a ligand.
We have examined the accuracy of Eq. 10 in more detail
(unpublished results). We find that accuracy decreases as
either the fraction of sites bound i/n or the fraction of ligand
surface covered by receptors ia/A increases. In other words,
Eq. 10 is less accurate when the surface of the ligand is
tightly packed with receptors, as can be expected. Thus,
under conditions that favor close packing of receptors on the
ligand surface, such as a receptor concentration in excess of
ligand concentration or a large cross-linking constant, the
usefulness of Eq. 10 should be checked. We expect that the
results of this analysis are typical for the approximate ex-
pressions in Table 1, because all of these expressions were
derived by the same method.
Steric effects on ligand-receptor equilibria
Equilibrium cross-linking curves are shown in Fig. 7 for
cases where steric effects do and do not influence binding.
Cross-linking, as measured by (2) or (10) (Eq. 18), is
plotted as a function of ligand concentration for two ligands.
One ligand has ordered sites, which all can be bound simul-
taneously, and the other ligand has randomly distributed
sites, not all of which can be bound simultaneously, because
of potential for steric exclusion of ligand sites by bound
receptors. To ensure a controlled comparison, the two li-
gands are otherwise identical.
FIGURE 6 Insertion probabilities for ligands with randomly distributed
sites. The fraction of sites available for receptor binding, Pi()  (i)/n, is
plotted as a function of the fraction of sites bound, i/n. (A) Ligand sites are
distributed along a one-dimensional ring (Case 3 in Table 1); l/L  0.01.
(B) Ligand sites are distributed over a two-dimensional surface (Case 1 in
Table 1); a/A  0.01 and 	  1. In each panel, the solid line corresponds
to a ligand with n  100, the broken line corresponds to a ligand with n 
50, and the dashed line corresponds to a ligand with n 20. The dotted line
corresponds to a ligand with sites ordered such that H(i)  1. Numerical
results are represented by points.
FIGURE 7 Equilibrium cross-linking curves. (A) (2) and (B) (10) are
plotted as a function of vKLT. The binding curves are determined by
solving Eq. 13 with the following parameter values: n  20, KxRT  10,
and vKCRT  1. The dotted line is for a ligand with ordered sites and H(i)
 1. The broken and solid lines are for a ligand with sites distributed
randomly in two dimensions and H(i)  1. To plot the broken line, we
calculate H(i) by using Eq. 10 with a/A  0.01. To plot the solid line, we
calculate H(i) by using Eq. 12 and the following values for Pi() for i 
1, . . . , 19: 0.9120, 0.8282, 0.7482, 0.6715, 0.598, 0.527, 0.458, 0.392,
0.328, 0.265, 0.205, 0.149, 0.100, 0.062, 0.037, 0.0216, 0.0119, 0.0060,
and 0.0024. These values are determined with the combinatoric algorithm
for the case where a is circular, A is square with periodic boundary
conditions, and a/A  0.01.
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In the comparison of Fig. 7 A, we see that steric effects on
equilibrium cross-linking, as measured by (2), are minor.
Essentially the same fraction of receptors are aggregated in
the presence or absence of steric effects. This result is
typical for other cases that we have examined. However, as
illustrated in Fig. 7 B, steric effects can significantly influ-
ence the distribution of receptor aggregates. Steric effects
inhibit the formation of higher-order complexes, such as
immunons. As can be seen, the peak fraction of receptors in
immunons, which is given by (10), is reduced by approx-
imately twofold because of steric effects. This result sug-
gests that steric effects on ligand-receptor binding can have
different consequences for cellular responses, depending on
how the cell senses receptor aggregation. One can expect
signals that are triggered by dimeric and larger aggregates to
be less sensitive to steric effects than signals that are trig-
gered only by oligomeric aggregates.
By comparing the broken and solid lines in Fig. 7, we can
see that Eq. 10, an approximate expression, is capable of
accurately modeling steric effects on equilibrium cross-linking.
Steric effects on ligand-receptor kinetics
Time courses of ligand-receptor binding are shown in Fig. 8
for cases where steric effects do and do not influence
binding. As in Fig. 7, we consider a ligand with ordered
sites, which all can be bound simultaneously, and a ligand
with randomly distributed sites, only a fraction of which can
be bound simultaneously because of the potential for steric
exclusion of ligand sites by bound receptors.
For the time courses of Fig. 8, ligand is initially in
solution. As time progresses, ligand-receptor binding leads
to the formation of receptor aggregates on the cell surface.
In the upper panel, we follow the fraction of receptors in
aggregates of all sizes, which is given by (2), and in the
lower panel, we follow the fraction of receptors in aggre-
gates of 10 or more receptors, which is given by (10). As
can be seen, steric effects limit the fraction of receptors that
are ultimately aggregated, as we observed earlier (Fig. 7).
Steric effects also slow the temporal formation of aggre-
gates. For example, in Fig. 8 B, the value of (10) reaches
a value of 0.2 faster for the ligand with ordered sites than for
the ligand with randomly distributed sites. As we noted
earlier, steric hindrance has a greater effect on higher order
ligand-receptor complexes than on lower-order complexes.
The fraction of receptors in aggregates of all sizes is com-
parable with or without steric effects (Fig. 8 A), but the
fraction of receptors in large aggregates is significantly
different when steric effects are present or absent (Fig. 8 B).
By comparing the broken and solid lines in Fig. 8, we can
see that Eq. 10 is capable of accurately modeling steric
effects on ligand-receptor binding kinetics.
DISCUSSION
The present work was motivated by our interest in immu-
noreceptors. When immunoreceptors are aggregated
through interactions with an antigen, signals are generated
that lead to cellular activation (Metzger, 1992). This process
is best characterized for FcRI, the high-affinity receptor for
IgE, and the immunoglobulin receptor on B cells. Signals
induced by aggregation of these receptors depend on vari-
ous properties of the aggregates that are formed on the cell
surface, such as the size of aggregates (Fewtrell and
Metzger, 1980; Dintzis et al., 1976) and the time that
individual receptors spend in aggregates (Torigoe et al.,
1998). These properties in turn depend on the properties of
the ligand that mediates receptor aggregation.
Different types of ligands have been used in quantitative
studies of receptor aggregation, such as symmetrical biva-
lent haptens and haptenated proteins and polysaccharides.
The binding of bivalent haptens to immunoglobulin recep-
tors has been well studied both theoretically and experimen-
tally (Dembo and Goldstein, 1978; Perelson and DeLisi,
1980; Posner et al., 1995b; Holowka and Baird, 1996).
However, bivalent ligands typically stimulate only weak
FIGURE 8 Time courses of ligand-receptor binding. The fraction of
receptors in (A) aggregates of two or more receptors (2) and in (B)
aggregates of 10 or more receptors (10) is plotted as a function of the
scaled time kxt. Initially, ligand is in solution. Time courses are deter-
mined by solving Eqs. 15–17 with the following parameter values: vKLT
1, KxRT  10, n  20, CRT/LT  10, and k r /kx  1. The dotted line is
for a ligand with ordered sites and H(i)  1. The broken and solid lines are
for a ligand with sites distributed randomly in two dimensions and H(i) 
1. To plot the broken line, we calculate H(i) by using Eq. 10 with a/A 
0.01. To plot the solid line, we calculate H(i) by using Eq. 12 and the
numerical values for Pi() given in Fig. 7.
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cellular responses (Kane et al., 1986; Posner et al., 1995a),
which limits their usefulness for studying events that follow
receptor aggregation. Multivalent ligands can be used to
generate strong cellular responses, but the kinetics and
thermodynamics of their interactions with receptors have
been more difficult to study, and a complete theoretical
understanding is not yet at hand. Here we have focused on
methods for including steric hindrance effects in both ki-
netic and equilibrium binding calculations.
When a single site on a multivalent ligand binds to a cell
surface receptor, nearby sites on the ligand may not be
available for binding because receptors have a finite size
and can “cover” sites and “exclude” others by preventing
receptors from getting close enough to bind them. Here we
have developed a theoretical framework for modeling steric
exclusion of potential ligand sites by bound cell surface
receptors. In this framework, steric effects on ligand-recep-
tor binding are characterized by a steric hindrance factor,
H(i) (Eq. 11), which gives the fraction of unbound ligand
sites that are available for receptor binding as a function of
i, the number of ligand sites already occupied by receptors.
The functional form of H(i) depends on the size of the
receptor and the spacing of ligand binding sites. We derived
analytical expressions for H(i) that apply under different
circumstances (Table 1). These expressions are relevant for
receptors that cover a compact region on the ligand surface
and for ligands such as linear polymers, proteins, and vi-
ruses. In addition, we have presented numerical algorithms
that can be used to calculate steric hindrance factors for
other types of ligands and receptors.
We derived both exact and approximate expressions for
steric hindrance factors (Table 1). To test the accuracy and
usefulness of the approximate expressions, we used them to
calculate insertion probabilities (Figs. 5 and 6). We then
compared these insertion probabilities with those calculated
using either a combinatoric or Monte Carlo algorithm. The
approximate and numerical results are in close agreement
for the cases that we examined. Because all of the expres-
sions in Table 1 were derived by the same method, we
focused on one approximate expression (Eq. 10), the equa-
tion for a ligand with sites randomly distributed in two
dimensions. This type of ligand corresponds to a haptenated
protein. We found, for the cases examined in Figs. 7 and 8,
that this approximate expression is adequate for quantifying
steric hindrance effects on both the kinetic and equilibrium
behaviors of ligand-receptor binding.
Figs. 7 and 8 indicate that the fraction of receptors in
large aggregates is more sensitive to steric effects than the
fraction of receptors in aggregates of all sizes. Thus trans-
membrane signals that are generated in response to large
aggregates may be sensitive not only to the number of
binding sites per ligand, but also to the arrangement and
spacing of ligand sites, which in turn are related to the
overall size of the ligand.
In this paper we have focused on steric effects that
influence receptor binding due to the exclusion of ligand
sites by bound receptors. However, steric effects also can
influence ligand adsorption to a cell if a bound ligand can
sterically hinder the binding of other ligands to unbound
receptors. This might occur if the ligand were large, as in
the case of a bacterium binding to a cell, and in circum-
stances where receptor mobility is impeded. Stankowski
(1984) discusses steric effects on ligand adsorption and
suggests an approach for modeling these effects.
A number of theories and methods are available for
modeling steric effects on adsorption reactions. For exam-
ple, McGhee and von Hippel (1974) and others (Schwarz,
1977; Epstein, 1978; Reiter and Epstein, 1990; Badcoe,
1992; Di Cera and Kong, 1996) have developed theories and
methods for modeling the binding of “large” ligands, which
cover more than one site, to one-dimensional lattices of
binding sites. The equations of McGhee and von Hippel
have been widely used to analyze the binding of proteins to
DNA. Similarly, Stankowski (1983, 1984) and others
(Tamm and Bartoldus, 1988; Cowan and Underwood, 1988;
Schaaf and Talbot, 1989; Chatelier and Minton, 1996; Sild
et al., 1996) have developed methods for modeling the
binding of large ligands to two-dimensional lattices of bind-
ing sites and potential surfaces. The theory developed here
is distinguished from earlier work for several reasons: 1)
We have considered steric effects on adsorption reactions in
the specific context of a multivalent ligand binding to cell
surface receptors. Steric effects on equilibrium and kinetic
binding are characterized by a steric hindrance factor, which
we have introduced into a previously developed model for
ligand-receptor binding (Perelson, 1984; Lauffenburger and
Linderman, 1993). 2) We have considered adsorption at
randomly distributed sites, which is important for analyzing
the binding of haptenated carrier molecules to cell surface
antibodies. Most earlier work has focused on adsorption at
regularly ordered sites or adsorption to a surface on which
all points can potentially serve as a binding site. An excep-
tion is the study of Macken and Perelson (1986), in which
equilibrium binding to a one-dimensional random distribu-
tion of sites was considered. 3) We have accounted for a
wide array of cases (Table 1) with a single general ap-
proach. We also have presented numerical algorithms that
can be used to calculate steric hindrance factors for any
conceivable case.
The theory that we have developed for quantifying steric
effects on ligand-receptor binding is closely related to sta-
tistical thermodynamic theories for one- and two-dimen-
sional fluids of hard-core particles. A bound receptor that
covers a circular area on the surface of a ligand is analogous
to a hard disk in a two-dimensional fluid of hard disks. In
thermodynamics, the insertion probability, the probability
of adding a particle to a fluid without overlap, is related to
the excess chemical potential of the fluid (Widom, 1963). A
number of methods are available for calculating insertion
probabilities, both numerically and in closed form. Here we
have adapted some of these methods (Andrews, 1975, 1976;
Boublı´k, 1975; Siepmann et al., 1992) to calculate insertion
probabilities that are relevant for ligand-receptor binding.
These methods required modification, because on the sur-
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face of a ligand, a bound receptor is constrained to particular
ligand sites, whereas in a thermodynamic fluid, a particle
can be located potentially anywhere. Our expressions for
insertion probabilities (Table 1) reduce to expressions for
hard-core particle fluids in the limit n 3 .
The model that we have developed is for a monovalent
receptor or for the case in which the sites on a multivalent
receptor are assumed to act independently, as is assumed in
equivalent site models. The model also applies to experi-
mental systems, such as the basophil and related cell lines
that express FcRI, in which bispecific chimeric antibodies
can be used as receptors. These antibodies are effectively
monovalent, because the specificity of each Fab arm is
different. To extend our theory to multivalent receptors in
which the structure of the receptor is explicitly taken into
consideration is beyond the scope of this paper. Macken and
Perelson (1986) have modeled the size and range of possible
motions of the two Fab arms of immunoglobulin receptors
in their study of the binding of a bivalent antibody to a
linear antigen with randomly distributed binding sites. Wie-
gel and Goldstein (1987) have considered the binding of a
bivalent antibody to a linear antigen with regularly ordered
binding sites. Tamm and Bartoldus (1988) have considered
the binding of a bivalent antibody to lipid membranes.
The main result reported here is the development of new
methods for increasing the realism of models for multiva-
lent ligand-receptor binding by taking steric hindrance ef-
fects into consideration. We believe these improvements
will have importance in a variety of studies examining
cellular responses to complex antigens, such as haptenated
proteins. Theoretical and experimental efforts to understand
such systems are of current and increasing interest (Sulzer
and Perelson, 1997; Xu et al., 1998; Hlavacek et al., 1999).
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